Table 1.
Demographics and treatments
| Patient No./Gender/Age (years) | Histological Diagnosis | Treatment |
||||||
|---|---|---|---|---|---|---|---|---|
| Surgery |
Radiation |
Chemotherapeutic Agents | Steroids (mg/day) | Bevacizumab (mg/kg) | ||||
| Type | Time Interval (months) | Dose (Gy) | Time Interval (months) | |||||
| 1/M/50 | Glioblastoma multiforme | GTR | 6 | 59.4 | 4 | — | — | — |
| 2/M/50 | Glioblastoma multiforme | BX | 9 | 59.4 | 7 | C, T | 4 | 10 |
| 3/F/46 | Glioblastoma multiforme | STR | 14 | 59.4 | 13 | L | 12 | — |
| 4/M/19 | Glioblastoma multiforme | GTR | 5 | 59.4 | 2 | — | 12 | — |
| 5/M/19 | Glioblastoma multiforme | GTR | 8 | 59.4 | 5 | T | 12 | 5 |
| 6/M/56 | Glioblastoma multiforme | PR | 32 | 59.4 | 29 | T | — | — |
| 7/F/57 | Glioblastoma multiforme | GTR | 9 | 59.4 | 6 | T | — | — |
| 8/F/57 | Glioblastoma multiforme | GTR | 12 | 59.4 | 9 | T | — | — |
| 9/M/54 | Glioblastoma multiforme | PR | 3 | 59.4 | 1 | — | 12 | — |
| 10/M/62 | Glioblastoma multiforme | GTR | 5 | 60 | 2 | — | 4 | — |
| 11/M/62 | Glioblastoma multiforme | GTR | 6 | 60 | 4 | T | — | 5 |
| 12/F/62 | Glioblastoma multiforme | PR | 7 | 60 | 3 | T | 8 | — |
| 13/M/32 | Anaplastic oligodendroglioma | GTR | 54 | — | — | — | — | — |
| 14/F/58 | Anaplastic ependymoma | GTR | 8 | 57.5 | 7 | C | 20 | 5 |
| 15/M/51 | Anaplastic astrocytoma | BX | 5 | 59.4 | 3 | — | 16 | — |
| 16/F/33 | Anaplastic astrocytoma | BX | 71 | 59.4 | 70 | I | 16 | 5 |
| 17/M/26 | Pilocytic astrocytoma | PR | 153 | 50.4 | 11 | — | — | — |
| 18/M/31 | Astroblastoma | GTR | 21 | 54 | 20 | — | — | — |
| 19/M/44 | Pineoblastoma | GTR | 87 | 50.4 | 72 | — | — | — |
| 20/M/46 | Angiocentric T-cell lymphoma | BX | 3 | — | — | — | — | — |
| 21/M/40 | Nasopharyngeal carcinoma metastasis | BX | 44 | 61.5 | 24 | — | — | — |
| 22/M/35 | Melanoma metastasis | STR | 28 | 48 | 28 | — | — | — |
| 23/F/72 | Non small cell lung carcinoma metastasis | GTR | 25 | 35 | 12 | — | 16 | — |
| 24/F/49 | Meningioma | PR | 255 | 50.4 | 309 | — | — | — |
| 25/M/53 | Meningioma | STR | 44 | 50.4 | 10 | — | — | — |
| 26/M/59 | Non secreting pituitary adenoma | GTR | 115 | 0.5 | 110 | — | — | — |
BX, biopsy; PR, partial resection; STR, subtotal resection; GTR, gross total resection C, carboplatin; I, irinotecan; L, lomustine; T, temozolomide.